Does the orphan medicinal product regulation assist or hinder access to innovative haemophilia treatment in Europe ?

B. O'Mahony, F. Peyvandi, A. Bok

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)455-458
Number of pages4
JournalHaemophilia
Volume20
Issue number4
DOIs
Publication statusPublished - 2014

ASJC Scopus subject areas

  • Hematology
  • Genetics(clinical)
  • Medicine(all)

Cite this

Does the orphan medicinal product regulation assist or hinder access to innovative haemophilia treatment in Europe ? / O'Mahony, B.; Peyvandi, F.; Bok, A.

In: Haemophilia, Vol. 20, No. 4, 2014, p. 455-458.

Research output: Contribution to journalArticle

@article{6b1219ccd8ce43babcef0e1aa274bb35,
title = "Does the orphan medicinal product regulation assist or hinder access to innovative haemophilia treatment in Europe ?",
author = "B. O'Mahony and F. Peyvandi and A. Bok",
year = "2014",
doi = "10.1111/hae.12462",
language = "English",
volume = "20",
pages = "455--458",
journal = "Haemophilia",
issn = "1351-8216",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "4",

}

TY - JOUR

T1 - Does the orphan medicinal product regulation assist or hinder access to innovative haemophilia treatment in Europe ?

AU - O'Mahony, B.

AU - Peyvandi, F.

AU - Bok, A.

PY - 2014

Y1 - 2014

UR - http://www.scopus.com/inward/record.url?scp=84904597184&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84904597184&partnerID=8YFLogxK

U2 - 10.1111/hae.12462

DO - 10.1111/hae.12462

M3 - Article

C2 - 24805888

AN - SCOPUS:84904597184

VL - 20

SP - 455

EP - 458

JO - Haemophilia

JF - Haemophilia

SN - 1351-8216

IS - 4

ER -